Skip to content
Screener

Amgen AMGN Prepaid & Other Current

Prepaid & Other Current at other companies

Eli Lilly logo
Eli LillyLLY
$15.37B-14.7%
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$801.7M+39.6%
Nektar Therapeutics logo
Nektar TherapeuticsNKTR
$20.44M+81.2%
Oruka Therapeutics, Inc. logo
Oruka Therapeutics, Inc.ORKA
$6.42M+115%
Rigel Pharmaceuticals logo
Rigel PharmaceuticalsRIGL
$25.75M+10.7%
Jazz Pharmaceuticals logo
Jazz PharmaceuticalsJAZZ
$149.7M-0.4%

Other financials

Income statement

See full
Revenue$10.1B+9.5%
Gross profit$7.2B+17.4%
Operating income$3.5B+32.3%
Net income$2.4B+65.9%
EPS (diluted)$4.37+64.9%

Balance sheet

See full
Cash & equivalents$574.0M+5.9%
Total debt$57.3B+2.0%
Total equity$11.7B+57.4%
Total assets$95.6B+8.8%

Cash flow

See full
Operating cash flow$4.0B+75.5%
CapEx$513.0M+39.0%
Free cash flow$3.5B+82.6%

Valuation

See full
Market cap$220.64B+44.0%
Enterprise value$277.37B+32.8%
P/E25.2×+2.1×
P/S5.8×+1.4×

Profitability

See full
Gross margin69.5%+5.0pp
Operating margin30%+6.5pp
Net margin23%+4.0pp
FCF margin26.7%-3.7pp

Returns & leverage

See full
Return on equity91.5%-7.7pp
Debt / equity4.9×-2.7×
Current ratio1.4×+0.1×

Where this comes from

Reported directly by Amgen in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsCurrent.

The source filing: Amgen’s 10-Q, filed August 5, 2026.

Filed
Aug 4, 2026, 8:00 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0000318154-26-000126
Line itemJune 30, 2026December 31, 2025
Cash and cash equivalents$13,989$9,129
Trade receivables, net10,2279,570
Inventories6,2206,225
Other current assets4,5254,133
Total current assets34,96129,057
Property, plant and equipment, net8,5477,913
Intangible assets, net20,48722,276
Goodwill18,66818,680

Item 1. FINANCIAL STATEMENTS

FAQ

What is Amgen's prepaid & other current?
Amgen (AMGN) reported prepaid & other current of $4.53B in Q2 2026.
How has Amgen's prepaid & other current changed year-over-year?
Amgen's prepaid & other current increased by 32.2% year-over-year, from $3.42B to $4.53B.
What is the long-term trend for Amgen's prepaid & other current?
Over 5 years (2020 to 2025), Amgen's prepaid & other current has grown at a 14.7% compound annual growth rate (CAGR), from $2.08B to $4.13B.
What does prepaid & other current mean?
Advance payments for expenses (rent, insurance, subscriptions) plus miscellaneous current assets not classified elsewhere.

Ask your AI about Amgen's prepaid & other current.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude